Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases

<div>Overall survival according to the expression of pentose phosphate pathway-related proteins in bone metastases (a) and lung metastases (b). Shorter overall survival is associated with 6PGL positivity in bone metastases and 6PGDH positivity in lung metastases.</div>

Disease Markers

fig4

Figure 4

Figure 4: Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases 